Skip to main content

Advertisement

SpringerLink
Log in

Down-regulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats

  • Organ Toxicity and Mechanisms
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

Hepatic drug metabolism is impaired in experimental animals and humans with renal diseases. An anticancer drug, cisplatin induces acute renal failure (ARF) in rats. Under the same experimental conditions, cisplatin causes down-regulation of hepatic cytochrome P450 (P450) enzymes in an isozyme selective manner. The present study examined the pathological role of ARF in the down-regulation of hepatic P450 enzymes in the cisplatin-treated rats. Male rats with single dose of intraperitoneally cisplatin (5 mg/kg) caused marked changes in renal parameters, BUN and serum creatinine but not hepatic parameters, serum alanine aminotransferase or aspartate aminotransferase. The rats also suffered from down-regulation of hepatic microsomal CYP2C11 and CYP3A2, male specific P450 isozymes, but not CYP1A2, CYP2E1, or CYP2D2. The decrease in serum testosterone level was also observed in injured rats, which was consistent with the selective effects on male specific P450 enzymes. Protection of rats against cisplatin-induced ARF by dimethylthiourea, a hydroxyl radical scavenger, also protected rats against the decrease in serum testosterone levels and the down-regulation of CYP2C11 and CYP3A2. Carboplatin, an analogue to cisplatin but no ARF inducer, did not cause decrease in serum testosterone levels and down-regulation of hepatic male specific P450 enzymes. These results suggest that down-regulation of hepatic P450 enzymes in male rats given cisplatin is closely related to the cisplatin-induced ARF and the resultant impairment of testis function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  • Baliga R, Zhang Z, Baliga M, Ueda N, Shah SV (1998) In vitro and in vivo evidence suggesting a role for iron in cisplatin-induced nephrotoxicity. Kidney Int 53:394–401

    Article  PubMed  CAS  Google Scholar 

  • Baumhakel M, Kasel D, Rao-Schymanski RA, Bocker R, Beckurts KT, Zaigler M, Barthold D, Fuhr U (2001) Screening for inhibitory effects of antineoplastic agents on CYP3A4 in human liver microsomes. Int J Clin Pharmacol Ther 39:517–528

    PubMed  CAS  Google Scholar 

  • Blacker C, Provost M, Kerdelhue B, Scholler R (1991) Testicular function in uremic rats: in vivo assessment of testosterone biogenesis. J Steroid Biochem Mol Biol 39:395–403

    Article  PubMed  CAS  Google Scholar 

  • Dreisbach AW, Lertora JJ (2003) The effect of chronic renal failure on hepatic drug metabolism and drug disposition. Semin Dial 16:45–50

    Article  PubMed  Google Scholar 

  • Guevin C, Michaud J, Naud J, Leblond FA, Pichette V (2002) Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators. Br J Pharmacol 137:1039–1046

    Article  PubMed  CAS  Google Scholar 

  • Handelsman DJ, Spaliviero JA, Turtle JR (1985) Testicular function in experimental uremia. Endocrinology 117:1974–1983

    Article  PubMed  CAS  Google Scholar 

  • Korashy HM, Elbekai RH, El-Kadi AO (2004) Effects of renal diseases on the regulation and expression of renal and hepatic drug-metabolizing enzymes: a review. Xenobiotica 34:1–29

    Article  PubMed  CAS  Google Scholar 

  • LeBlanc GA, Waxman DJ (1988) Feminization of rat hepatic P-450 expression by cisplatin. Evidence for perturbations in the hormonal regulation of steroid-metabolizing enzymes. J Biol Chem 263:15732–15739

    PubMed  CAS  Google Scholar 

  • Leblond F, Guevin C, Demers C, Pellerin I, Gascon-Barre M, Pichette V (2001) Downregulation of hepatic cytochrome P450 in chronic renal failure. J Am Soc Nephrol 12:326–332

    Article  PubMed  CAS  Google Scholar 

  • Liu H, Baliga M, Baliga R (2002) Effect of cytochrome P450 2E1 inhibitors on cisplatin-induced cytotoxicity to renal proximal tubular epithelial cells. Anticancer Res 22:863–868

    PubMed  Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    PubMed  CAS  Google Scholar 

  • Masubuchi Y, Horie T (2003) Resistance to indomethacin-induced down-regulation of hepatic cytochrome P450 enzymes in the mice with non-functional Toll-like receptor 4. J Hepatol 39:349–356

    Article  PubMed  CAS  Google Scholar 

  • Masubuchi Y, Horie T (2004) Endotoxin-mediated disturbance of hepatic cytochrome P450 function and development of endotoxin tolerance in the rat model of dextran sulfate sodium-induced experimental colitis. Drug Metab Dispos 32:437–441

    Article  PubMed  CAS  Google Scholar 

  • Masubuchi Y, Kagimoto N, Narimatsu S, Fujita S, Suzuki T (1993) Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes. Drug Metab Dispos 21:1012–1016

    PubMed  CAS  Google Scholar 

  • Masubuchi Y, Masuda E, Horie T (2002) Multiple mechanisms in indomethacin-induced impairment of hepatic cytochrome P450 enzymes in rats. Gastroenterology 122:774–783

    Article  PubMed  CAS  Google Scholar 

  • McKeage MJ (1995) Comparative adverse effect profiles of platinum drugs. Drug Saf 13:228–244

    PubMed  CAS  Google Scholar 

  • Nisbeth U, Hallgren R, Eriksson O, Danielson BG (1987) Endotoxemia in chronic renal failure. Nephron 45:93–97

    PubMed  CAS  Google Scholar 

  • Nolin TD, Frye RF, Matzke GR, Pichette V, Leblond FA, Dreisbach AW, Lertora JJ (2003) Hepatic drug metabolism and transport in patients with kidney disease. Am J Kidney Dis 42:906–925

    Article  PubMed  CAS  Google Scholar 

  • Ohishi N, Imaoka S, Funae Y (1994) Changes in content of P450 isozymes in hepatic and renal microsomes of the male rat treated with cis-diamminedichloroplatinum. Xenobiotica 24:873–880

    PubMed  CAS  Google Scholar 

  • Omura T, Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370–2378

    PubMed  CAS  Google Scholar 

  • Pichette V, Leblond FA, Dreisbach AW, Lertora JJ (2003) Drug metabolism in chronic renal failure. Curr Drug Metab 4:91–103

    Article  PubMed  CAS  Google Scholar 

  • Safirstein R, Winston J, Goldstein M, Moel D, Dikman S, Guttenplan J (1986) Cisplatin nephrotoxicity. Am J Kidney Dis 8:356–367

    PubMed  CAS  Google Scholar 

  • Screnci D, McKeage MJ (1999) Platinum neurotoxicity: clinical profiles, experimental models and neuroprotective approaches. J Inorg Biochem 77:105–110

    Article  PubMed  CAS  Google Scholar 

  • Smogorzewski MJ, Massry SG (2003) Liver metabolism in CRF. Am J Kidney Dis 41:S127–S132

    Article  PubMed  CAS  Google Scholar 

  • Sun H, Huang Y, Frassetto L, Benet LZ (2004) Effects of uremic toxins on hepatic uptake and metabolism of erythromycin. Drug Metab Dispos 32:1239–1246

    Article  PubMed  CAS  Google Scholar 

  • Terao N, Shen DD (1983) Effect of experimental renal failure on the disposition kinetics of l-propranolol in rats. J Pharmacol Exp Ther 227:295–301

    PubMed  CAS  Google Scholar 

  • Terao N, Shen DD (1985) Reduced extraction of I-propranolol by perfused rat liver in the presence of uremic blood. J Pharmacol Exp Ther 233:277–284

    PubMed  CAS  Google Scholar 

  • Uchida N, Kurata N, Shimada K, Nishimura Y, Yasuda K, Hashimoto M, Uchida E, Yasuhara H (1995) Changes of hepatic microsomal oxidative drug metabolizing enzymes in chronic renal failure (CRF) rats by partial nephrectomy. Jpn J Pharmacol 68:431–439

    Article  PubMed  CAS  Google Scholar 

  • Waxman DJ, Chang TKH (2005) Hormonal regulation of liver cytochrome P450 enzymes. In: Ortiz De Montellano PR (ed) Cytochrome P450: structure, mechanism, and biochemistry. Kluwer/Plenum, New York, pp 347–376

    Google Scholar 

Download references

Acknowledgements

This study was supported in part by a grant-in-aid from the Ministry of Education, Science, and Culture of Japan.

Author information

Author notes

  1. Yasuhiro Masubuchi

    Present address: Laboratory of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Chiba Institute of Science, 15-8 Shiomi-cho, Choshi, 288-0025, Chiba, Japan

Authors and Affiliations

  1. Department of Biopharmaceutics, Graduate School of Pharmaceutical Sciences, Chiba University, 1-8-1 Inohana, Chuo-ku, 260-8675, Chiba, Japan

    Yasuhiro Masubuchi, Mamiko Kawasaki & Toshiharu Horie

Authors
  1. Yasuhiro Masubuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mamiko Kawasaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshiharu Horie
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Toshiharu Horie.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Masubuchi, Y., Kawasaki, M. & Horie, T. Down-regulation of hepatic cytochrome P450 enzymes associated with cisplatin-induced acute renal failure in male rats. Arch Toxicol 80, 347–353 (2006). https://doi.org/10.1007/s00204-006-0079-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-006-0079-z

Keywords

Search

Navigation